| Haemonetics |
Vascade MVP Venous Vascular Closure System (VVCS)
|
Extravascular, bioabsorbable closure device |
6–12 inner diameter (up to 15 maximum outer diameter) |
Utilizes existing procedural sheath |
Femoral venous access sites: 6 F–12 F inner diameter (up to 15 F maximum outer diameter) |
Fully integrated, extravascular, bioabsorbable femoral venous closure system that is easy to use, leaves no permanent components behind, and has demonstrated safety and efficacy in the AMBULATE trial, a prospective, multicenter, randomized clinical trial comparing Vascade MVP to manual compression; system combines Cardiva’s collapsible disc technology and a thrombogenic resorbable collagen patch in an integrated design; a multiaccess site indication is required for vascular closure devices to provide hemostasis in procedures that require more than one access site in the same vessel such as cardiac ablations; Vascade MVP Venous Vascular Closure System is indicated for this use |
| Haemonetics |
Vascade Vascular Closure System (VCS)
|
Extravascular, bioabsorbable closure device |
5, 6, 7 |
Utilizes existing procedural sheath |
Femoral arterial and femoral venous access sites (5 F, 6 F, or 7 F) |
Fully integrated, extravascular, bioabsorbable femoral access closure system that is easy to use, leaves no permanent components behind, and has demonstrated safety and efficacy in the RESPECT trial, a prospective, multicenter, randomized clinical trial comparing Vascade to manual compression; system combines Cardiva’s collapsible disc technology and a thrombogenic resorbable collagen patch in an integrated design; it enables rapid hemostasis while minimizing complications |